Rinsho Shinkeigaku (Clinical Neurology)


Coronavirus disease 2019 (COVID-19) and headaches

Keisuke Suzuki, M.D., Ph.D.1)

1) Department of Neurology, Dokkyo Medical University

Over the course of the new coronavirus infectious disease (coronavirus disease 2019; COVID-19) pandemic, our social situation has been changing dramatically, in addition to the substantial efforts made for the early and appropriate management of COVID-19 and preventing this infection spreading. Recently, neurological symptoms associated with COVID-19 have been shown to be not uncommon, with headaches receiving attention as one of the main neurological symptoms. The frequency of headaches associated with COVID-19 ranged from 5.6% to 70.3%, based on 21 clinical studies and 8 meta-analyses. However, headaches were observed in 11.1% to 81.0% of non-COVID-19 individuals, including healthcare workers caring for COVID-19 patients. Although detailed descriptions of headaches were rarely provided in the literature obtained, in this article, I wil discuss the frequency and characteristics of headaches, and the pathophysiology of headaches as it relateds to COVID-19.
Full Text of this Article in Japanese PDF (432K)

(CLINICA NEUROL, 60: 589|596, 2020)
key words: COVID-19, headache, neurological complications

(Received: 31-May-20)